Anti-influenza virus activity of Yinqin capsules

HUANG Hai,FENG Mei-qing,SUN Chuan-wen,XU Shu-guang,PU Junxue,ZHOU Pei

DOI: https://doi.org/10.3969/j.issn.1672-8467.2006.04.022

2006-01-01

Abstract:Purpose To study the antiviral activity of Yinqin capsules against influenza virus in vitro and in vivo. Methods The cell culture technique was used in MDCK cells to get cell viability of different concentration Yinqin capsules by MTT assay.And virus inhibitory rate was determined by Cytopathic effect assay.The in vivo anti-virus activity was performed on Kunming mice divided to receive oral Yinqin capsules in twice daily dose of 1.0,0.3 and 0.1 g/ kg for 6 days.The mean survival days and the pulmonary pathological lesions of the infected mice were observed to evaluate the therapeutic efficacy of Yinqin capsules. Results Yinqin capsules showed no toxicity to MDCK cells at 1.25 mg/mL,and could effectively inhibit influenza A_3 virus at 0.6 mg/mL in vitro.It indicated that(1.0,) 0.3 and 0.1 g/kg per day dosage medicine orally given bid for 6 days could reduce the death rate of the infected mice by 40%,20% and 5% respectively,and could prolong the mean survival days by(51.1%,) 29.1% and 23.4% respectively,and the pulmonary pathological lesions were reduced by(64.3%,)(56.1%) and 34.6% respectively. Conclusions Yinqin capsules is an effective anti-influenza virus compound in vitro and in vivo.